Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Nausea 1Lung Neoplasms 1Infiltrating Bladder Urothelial Carcinoma 1Fallopian Tube Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brenner Tumor 1

Interventions

Dexamethasone 9Calcium Dobesilate 8Aprepitant 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Palonosetron 4Granisetron 4Doxorubicin 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Psychiatric Rehabilitation 3Cyclophosphamide 3auricularum 2Yoga 2Surveys and Questionnaires 2Standard of Care 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Diphenhydramine 2Control Groups 2Acupuncture Therapy 2Acupressure 2salicylhydroxamic acid 1phenazine 1peppermint oil 1dolasetron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Vomiting × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT01275664 2018-05-22

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

GOG Foundation

Phase NA Terminated
4 enrolled 5 charts
Gynecologic

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡